Haiyin Capital
  • Home
  • About
  • Portfolio
  • Blog
  • Contact

American Biotech Start-Ups Head To China For Capital Partners

11/24/2014

0 Comments

 
by Benjamin Shobert, contributor to Forbes

Nestled in a quiet industrial park in Redmond, Washington, not too far from the Microsoft headquarters, is a small biotech start-up with both an interesting technology they are bringing to market, as well as a capital partner that suggests some ways in which global biotech research, venture capital and commercialization are going to change.

The company is Cerevast Therapeutics, the manufacturer of a non-invasive medical device that treats acute ischemic stroke through the use of acoustic energy delivered from a device the patient wears on their head immediately after they get to a stroke center and begin the IV delivery of blood-clot dissolving medicine. The device utilizes sixteen ultrasound transducers that project localized energy into the brain to disrupt blood clots where acute ischemic strokes occur through a process known as sonothrombolysis.

Founded in 2009, Cerevast recently announced that they had successfully passed the first interim analysis of their global phase 3 trial. This was certainly an important milestone for the company, but as Cerevast CEO Brad Zakes shared with me, the story behind the company’s Series C venture capital funding is also an interesting story. While Brad was out raising money, he was contacted by Haiyin Capital, a Chinese venture capital firm, who expressed a strong interest in learning more about Cerevast. This interest translated into a $5 million investment by Haiyin. While the amount was important, the ease with which Haiyin and Cerevast were able to come to terms was a breath of fresh air.

Click here to read the full article.
0 Comments

    Haiyin Capital

    We invest globally in breakout teams and technologies.

    Archives

    October 2015
    September 2015
    July 2015
    June 2015
    May 2015
    April 2015
    February 2015
    January 2015
    November 2014
    October 2014

    Categories

    All
    1366 Technologies
    AngelList
    Cerevast
    CircuitHub
    Haiyin
    Haiyin Capital
    LightSail Energy
    Martin Aircraft
    Terrafugia
    Wicab
    WiTricity
    XCOR

    RSS Feed

©2018, Haiyin Capital, Beijing, China